Tibben A, Duivenvoorden H J, Niermeijer M F, Vegter-van der Vlis M, Roos R A, Verhage F
Clinical Genetics Centre, University Hospital, Leiden, The Netherlands.
Psychosom Med. 1994 Nov-Dec;56(6):526-32. doi: 10.1097/00006842-199411000-00008.
This study assessed the 6-month follow-up effects of presymptomatic DNA testing for Huntington's disease (HD) in 73 individuals at 50% prior risk who were identified either as carriers of the HD gene (N = 29) or as noncarriers (N = 44). The subject's knowledge of being a gene carrier was expected to induce intrusive emotions, denial-avoidance behavior, and pessimistic expectancies of the future and adjustment problems. The Impact of Event Scale, the Beck Hopelessness Scale, and the General Health Questionnaire were used as standard measures of psychological distress. At the disclosure of the test results, carriers had a strong increase in pessimistic expectations but showed a decline to baseline levels 6 months later. Noncarriers reported a steep decline in hopelessness compared with their pretest conditions but had increased scores after 6 months. Six months after the disclosure of the test results, both gene carriers and noncarriers reported a significant decrease in unwanted intrusive thoughts about HD. Carriers showed a slight increase in denial-avoidance behavior, whereas noncarriers showed a clear decrease. Our observations might indicate that tested individuals found relief from the prior psychological distress and that they were able to acknowledge the impact of the test result on their future. An unresolved question is how the foreknowledge will affect carriers as they approach the impending onset of the disease. Longer observation periods (> 6 months after disclosure) are required to study changes of the impact of DNA test results over time.
本研究评估了对73名患亨廷顿病(HD)风险为50%的个体进行症状前DNA检测的6个月随访效果,这些个体被确定为HD基因携带者(N = 29)或非携带者(N = 44)。预计受试者知晓自己为基因携带者会引发侵入性情绪、否认回避行为、对未来的悲观预期以及适应问题。事件影响量表、贝克绝望量表和一般健康问卷被用作心理困扰的标准测量工具。在公布检测结果时,携带者的悲观预期大幅增加,但6个月后降至基线水平。与检测前相比,非携带者报告的绝望感急剧下降,但6个月后得分有所上升。在公布检测结果6个月后,基因携带者和非携带者均报告称,关于HD的不必要侵入性想法显著减少。携带者的否认回避行为略有增加,而非携带者则明显减少。我们的观察结果可能表明,接受检测的个体从之前的心理困扰中得到了缓解,并且他们能够认识到检测结果对其未来的影响。一个尚未解决的问题是,随着携带者接近疾病即将发作,这种预知会如何影响他们。需要更长的观察期(公布后>6个月)来研究DNA检测结果的影响随时间的变化。